Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley 

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

The Absence of Interleukin-6 Enhanced Arsenite-Induced Renal Injury by Promoting Autophagy of Tubular Epithelial Cells with Aberrant Extracellular Signal-Regulated.
Volume 54, Issue 6, Pages (January 1998)
Volume 68, Issue 6, Pages (December 2005)
Volume 60, Issue 6, Pages (December 2001)
Volume 63, Issue 6, Pages (June 2003)
IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers  Kidney.
Volume 55, Issue 3, Pages (March 1999)
Volume 55, Issue 2, Pages (February 1999)
Volume 71, Issue 3, Pages (February 2007)
Volume 58, Issue 5, Pages (November 2000)
Volume 79, Issue 4, Pages (February 2011)
Volume 66, Issue 3, Pages (September 2004)
Volume 64, Issue 1, Pages (July 2003)
Volume 68, Issue 6, Pages (December 2005)
Volume 61, Issue 2, (February 2002)
Volume 65, Issue 3, Pages (March 2004)
Volume 65, Issue 1, Pages (January 2004)
Volume 60, Issue 2, Pages (August 2001)
Volume 61, Issue 5, Pages (May 2002)
Volume 66, Issue 6, Pages (December 2004)
Volume 69, Issue 10, Pages (May 2006)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 53, Issue 5, Pages (May 1998)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Kameswaran Surendran, Theodore C. Simon, Helen Liapis, John K. McGuire 
Volume 87, Issue 2, Pages (February 2015)
Volume 56, Issue 5, Pages (November 1999)
Volume 73, Issue 4, Pages (February 2008)
Volume 63, Issue 4, Pages (April 2003)
Volume 70, Issue 12, Pages (December 2006)
Volume 59, Issue 1, Pages (January 2001)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers  Kidney.
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 77, Issue 9, Pages (May 2010)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 60, Issue 5, Pages (November 2001)
Aberrant Mineralization of Connective Tissues in a Mouse Model of Pseudoxanthoma Elasticum: Systemic and Local Regulatory Factors  Qiujie Jiang, Qiaoli.
Volume 70, Issue 7, Pages (October 2006)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 62, Issue 2, Pages (August 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 57, Issue 3, Pages (March 2000)
Volume 70, Issue 2, Pages (July 2006)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 3, Pages (September 1999)
Volume 59, Issue 2, Pages (February 2001)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 53, Issue 4, Pages (April 1998)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 58, Issue 2, Pages (August 2000)
Volume 57, Issue 6, Pages (June 2000)
Volume 68, Issue 2, Pages (August 2005)
Volume 80, Issue 5, Pages (September 2011)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 57, Issue 2, Pages (October 2000)
Volume 67, Issue 4, Pages (April 2005)
Volume 56, Issue 6, Pages (December 1999)
Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist  Scott E. Wenderfer, Stanislaw.
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Jun Wada, Hirofumi Makino, Yashpal S. Kanwar  Kidney International 
Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley 
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Volume 70, Issue 1, Pages (July 2006)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Gene transfer of RANTES elicits autoimmune renal injury in MRL-Faslpr mice  Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley  Kidney International  Volume 53, Issue 6, Pages 1631-1641 (June 1998) DOI: 10.1046/j.1523-1755.1998.00911.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 RANTES mRNA is expressed in MRL-Faslpr kidneys. Total RNA was extracted from kidney cortex of MRL-Faslpr mice 2, 4, and 6 months of age (lanes 1, 2, 3), congenic MRL-++ mice 2 and 10 months of age (lanes 4, 5), and normal C3H-++ mice five months of age (lane 6). A total of 20 μg of RNA was electrophoresed, blotted and hybridized with a DNA probe for mouse RANTES and reprobed with β-actin. Each time point reflects the pooled kidney cortex RNA from 3 mice. Results are representative of 2 separate experiments. Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Primary culture tubular epithelial cells (TEC) retrovirally transduced with the RANTES gene sequence constitutively express RANTES. (A) Northern analysis demonstrating expression of RANTES mRNA by transduced RANTES-TEC but not uninfected TEC. Total RNA (10 μg) from uninfected (lanes 1, 2) or RANTES-TEC (lanes 3, 4) derived from MRL-Faslpr or normal C3H-++ mice was hybridized with a DNA probe for mouse RANTES, and reprobed with β-actin. (B) Immunohistochemical staining documenting the expression of RANTES by transduced RANTES-TEC, but not uninfected TEC. RANTES-TEC (panel I) and uninfected TEC (panel II) from MRL-Faslpr (top) or C3H-++ (bottom) were incubated with goat anti-human RANTES-Ab and immunoreactivity was visualized with a rabbit anti-goat IgG-FITC conjugated Ab (magnification ×400). (C) Western analysis verifying secretion of RANTES by transduced RANTES-TEC, but not uninfected TEC. Cell culture supernatants from MRL-Faslpr and C3H-++ RANTES-TEC or uninfected TEC were subjected to Western analysis and RANTES protein was detected using a rabbit anti-murine RANTES Ab as described in the Methods section. Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 RANTES incites progressive renal injury. The progression of renal injury induced by RANTES-TEC in MRL-Faslpr, MRL-++ and C3H-++ mice was determined at 7 (▪), 14 (), and 28 () days post-Ix. Intrarenal lesions emanating from the subcapsular implant were scored according to the depth of infiltration into the kidney; 0 = none, 1 = cortex, 2 = inner cortex, 3 = medulla. Values are expressed as the mean ± SE; N ≥ 3 mice per group. * P < 0.05. Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 RANTES incites progressive renal injury. The progression of renal injury induced by RANTES-TEC in MRL-Faslpr, MRL-++ and C3H-++ mice was determined at 7 (▪), 14 (), and 28 () days post-Ix. Intrarenal lesions emanating from the subcapsular implant were scored according to the depth of infiltration into the kidney; 0 = none, 1 = cortex, 2 = inner cortex, 3 = medulla. Values are expressed as the mean ± SE; N ≥ 3 mice per group. * P < 0.05. Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 RANTES incites progressive renal injury. The progression of renal injury induced by RANTES-TEC in MRL-Faslpr, MRL-++ and C3H-++ mice was determined at 7 (▪), 14 (), and 28 () days post-Ix. Intrarenal lesions emanating from the subcapsular implant were scored according to the depth of infiltration into the kidney; 0 = none, 1 = cortex, 2 = inner cortex, 3 = medulla. Values are expressed as the mean ± SE; N ≥ 3 mice per group. * P < 0.05. Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 RANTES incites renal injury in autoimmune MRL-Faslpr, but not in C3H-++ mice with normal kidneys. RANTES-TEC incite a massive accumulation of mononuclear cells under the renal capsule (SC; subcapsule) that actively infiltrated into the kidney cortex (arrows) causing large interstitial lesions in autoimmune MRL-Faslpr mice (A). By contrast, RANTES-TEC placed under the renal capsule of normal C3H-++ mice, induce a modest accumulation of cells at 28 days post-Ix (B). Uninfected TEC (C) or TNF-TEC (D) placed under the renal capsule of MRL-Faslpr mice do not incite a renal lesion (paraffin-embedded tissue sections, hematoxylin and eosin stained; magnification ×400). Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 RANTES incites renal injury in autoimmune MRL-Faslpr, but not in C3H-++ mice with normal kidneys. RANTES-TEC incite a massive accumulation of mononuclear cells under the renal capsule (SC; subcapsule) that actively infiltrated into the kidney cortex (arrows) causing large interstitial lesions in autoimmune MRL-Faslpr mice (A). By contrast, RANTES-TEC placed under the renal capsule of normal C3H-++ mice, induce a modest accumulation of cells at 28 days post-Ix (B). Uninfected TEC (C) or TNF-TEC (D) placed under the renal capsule of MRL-Faslpr mice do not incite a renal lesion (paraffin-embedded tissue sections, hematoxylin and eosin stained; magnification ×400). Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 RANTES incites an accumulation of CD4+> CD8+ > DN T cells in MRL-Faslprkidneys. RANTES-TEC placed under the renal capsule of MRL-Faslpr mice, induce a predominant accumulation of CD4+ cells (dark staining) (a), and CD8+ cells (b) within the interstitial lesion at 28 days post-implantation (Ix). In contrast to CD4+ and CD8+ cells, Mø accumulate along the periphery of the lesion (c), and few DN T cells are observed within the lesion (d) (frozen tissue sections; magnification ×1000 for a and b; ×800 for c and d). Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 RANTES incites an interstitial and periglomerular accumulation of CD4+ T cells in MRL-Faslpr kidneys. RANTES-TEC placed under the renal capsule of MRL-Faslpr mice, induce a prominent accumulation of CD4+ T cells (dark staining; arrows) outside the induced lesion, surrounding glomeruli (A), and within the interstitium (B) at 28 days post-implantation (Ix) (frozen tissue sections; magnification A ×1200 and B ×400). Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 53, 1631-1641DOI: (10. 1046/j. 1523-1755 Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 53, 1631-1641DOI: (10. 1046/j. 1523-1755 Kidney International 1998 53, 1631-1641DOI: (10.1046/j.1523-1755.1998.00911.x) Copyright © 1998 International Society of Nephrology Terms and Conditions